201121419 六、發明說明： 【發明所屬之技術領域】 本發明係關於聚合物組成物及由該聚合物組成物成形 之模製品。 【先前技術】 由於可以相對低的成本獲得各種形狀之模製品，因此 於聚合物中含有活性化合物（如殺蟲劑）之聚合物組成物以 及由該聚合物組成物成形之模製品至今已為大眾所知且已 廣泛使用於各個領域。此等模製品係藉由下述方式顯現其 作用：使活性化合物蒸散，或使活性化合物滲漏至模製品 之表面，藉以釋出活性化合物，亦即所謂的滲出（b 1 eedi ng) (參見專利文獻1)。 當所使用之活性化合物具有低蒸散性質時，此化合物 將難以藉由其蒸散作用自模製品釋出，因而此化合物主要 是藉由滲出方式自模製品釋出。當模製品中所留存之活性 化合物的量超出聚合物的飽和量（為過飽和量）時，將會發 生滲出情形，而此即為過飽和量之活性化合物（=活性化合 物之添加量-活性化合物於模製品中之飽和量）隨時間遷移 至模製品表面的現象。當模製品是以含有超出飽和量之活 性化合物量的聚合物組成物成形時，該活性化合物將隨時 間滲出至模製品表面。然而，一般已知此滲出速率是隨著 活性化合物的最初添加量而顯著變化，且此滲出速率有隨 時間減小的趨勢。另一方面，當模製品是以「滲出活性化 合物」來顯現其作用時，可獲得所欲滲出速率之時間期即 321673 201121419 成為模製品有效期的指標。因此，一旦決定了模製品之有 效期，必然可決定該可釋放性活性化合物㈣⑽仏 active compound)的最初添加量。 為了獲得可長時間使用之模製品，需使用含有超出聚 合物飽和量的活性化合物之聚合物組成物。然而，使用該 於聚合物中含有過飽和量之活性化合物的聚合物組成物所 成形之模製品在其使用前期即會使大量活性化合物渗出， 因此無法於所欲之時間期内維持滲出速率。 專利文獻 1 : JP-A-6-315332 【發明内容】 依據發明人深入研究的結果，發現使用含有稀煙系聚 合物、活性化合物以及支鏈脂肪酸之稀烴系聚合物組成物 可有效防止活性化合物滲出速率的減小，因而可於預定之 時間期内提高活性化合物的滲出量。本發明係基於此發現 而完成。 亦即，本發明提供一種聚合物組成物，其包含： 重量份之烯烴系聚合物；以及相對於每100重量份之該烯 烴系聚合物為〇. 01至100重量份之支鏈脂肪酸與至 200重量份之可釋放性活性化合物。 本發月進步長:供由上述聚合物組成物成形之模製 品。 根據本發明，可防止活性化合物滲出速率的減小，因 此可提供能於預定時間期内提高活性化合物滲出量的聚合 物組成物，以及由該聚合物組成物成形之模製品。 321673 201121419 【實施方式】 本發明提供一種聚合物組成物，其包含：100重量份 之烯烴系聚合物；以及相對於每100重量份之該烯烴系聚 合物為0.01至100重量份之支鏈脂肪酸與0.01至200重 量份之可釋放性活性化合物。 本發明之「可釋放性活性化合物」中的術語「可釋放 性」係意指活性化合物可從該由聚合物組成物成形之模製 品滲出並滲漏至模製品之表面。 可釋放性活性化合物為可顯現下述相關作用之有機化 合物：昆蟲防治、抗菌、防黴、防污、除草、植物生長調 節、經皮治療（percutaneous treatment)、防錄、潤滑、 表面活化或抗靜電效用。此等有機化合物可單獨使用或組 合使用。關於可釋放性活性化合物，較佳係使用選自下列 所組成群組之化合物：昆蟲防治劑、潤滑劑、抗靜電劑以 及防霧劑。 由可釋放性活性化合物之效用的觀點來看，相對於聚 合物組成物中所含每100重量份之烯烴系聚合物，該可釋 放性活性化合物之添加量較佳為0. 01重量份或，更多，更佳 為0.1重量份或更多。再者，由抑制所得模製品之黏性的 觀點來看，相對每100重量份之烯烴系聚合物，該可釋放 性活性化合物之添加量較佳為200重量份或更少，更佳為 100重量份或更少，又更佳為50重量份或更少。 當使用昆蟲防治劑作為具有昆蟲防洽活;:徑透有機化合 物時，可使用下述昆蟲防治化合物，例如：殺蟲劑、昆蟲 5 321673 201121419 生長調節劑、昆蟲驅除劑等。可組合使用可用於提高昆蟲 防治劑效用之化合物（亦即，增效劑）。增效劑之實例包含 胡椒基丁醚（piperonyl butoxide)、八氯二丙醚、硫氰基 乙酸異莰酯（thiocyanoacetic isobornyl)、N-(2-乙基己 基）-雙環[2, 2, 1]-庚-5-烯-2, 3-二羧醯亞胺、N-(2-乙基己 基）-1-異丙基-4-曱基環[2, 2, 2]辛-5-稀-2, 3-二叛醯亞胺 等。 殺蟲劑之實例包含除蟲菊類（pyrethroid-based)化合 物、有機磷類化合物、胺基曱酸酯類化合物、苯基吡唑類 化合物等。除蟲菊類化合物之實例包含百滅寧 (permethrin)、亞列寧（aiiethrin)、異亞列寧 (d-allethrin)、dd-亞列寧（dd-allethrin)、異治滅寧 (d-tetramethrin)、普亞列寧（praiiethrin)、赛酚寧 (cyphenothrin)、右旋苯酸菊醋（d-phenothrin)、異列滅 寧（d-resmethrin)、益避寧（empenthrin)、芬化利 (fenvalerate)、盈化利（esfenvaierate)、芬普寧 (fe叩ropathrin)、賽洛寧(；cyhalothrin)、賽扶寧 (cyfluthrin)、依芬寧（et〇;fenpr〇x)、泰滅寧 (tralomethrin)、賜百寧（esbi〇thrin)、拜富寧 (benfluthrin)、環戊稀丙菊酯（teraiiethrin)、第滅寧 (deltamethrin)、盼丁滅寧（phen〇thrin)、汰福寧 (tefluthrin)、畢芬寧（bifenthrin)、賽扶寧 (cyfluthrin)、赛紛寧（Cyphen〇thrin)、賽滅寧 (cypermethrin)、亞滅寧（_Cypermethrin)等。有機磷類 321673 6 201121419 化合物之貝例包含撲滅松（fenitr〇thi〇n)、敵敵畏 (dichlorovos)、乃力松（naled)、芬殺松（fenthi〇n)、氡 • 乃松（cyanophos)、陶斯松（chl〇rpyrif〇s)、卡克弗 (calclofos)、杈力松（salithi〇n)、大利松（diazin〇n)等。 胺基曱酸酯類化合物之實例包含惡蟲酮 (methoxydiazon)、安丹（pr〇p〇xur)、丁基滅必蝨 (fenobucarb)、加保利（carbaryl)等。苯基吡唑類化合物 之實例包含芬普尼（fipr〇nil)等。 昆蟲生長調節劑之實例包含百利普芬 (pyriproxfen)、美賜平（meth〇prene)、烯蟲乙酯 (hydroprene)、二福隆（diflubenzur〇n)、賽滅淨 (cyromazine)、分諾克（phen〇xycarb)、祿芬隆（lufenur〇n) 等。 昆蟲驅除劑之實例包含待乙妥（diethyl toluamide)、鄰笨二甲酸二丁酯等。 關於昆蟲防治劑，較佳者為殺蟲劑，更佳者為除蟲菊 類化合物。尤其，又更佳者為在25°c時顯現低於^1〇_6毫 米汞柱（mmHg)之蒸氣壓的除蟲菊類化合物。關於此等除蟲 菊類化合物，例示者為列滅寧、百滅寧等。 藉由上述昆蟲防治劑防治之昆蟲的實例為節肢動物門 (Arthropoda)，例如蛛蜘、壁蝨及昆蟲。其實例如下：屬 於蟎蜱目（Acarina)之林禽刺蟎（0rmith〇nyssus sylviarum)、掛桔葉蜗（citrus red mite)、腐食路蜗 (Tyrophagusputrescentiae)等；屬於蛛形綱（Arachnjda) 321673 7 201121419 蜘蛛目（Araneae)之卡氏地蛛（Atypus karshi)、室内幽靈 蛛（Pholcus phalangioides)等；屬於蚰蜒目 (Scutigeromorpha)之蚰蜒（Thereuopoda clunifera)等； 屬於唇足綱（Chilopoda)石娱虫公目（Lithobiomorpha)之背 石蜈蚣（Bothropolys asperatus)等；以及屬於唇足綱 (Chilopoda)條馬陸目（Polydesmoidea)之溫室馬陸 (Oxidus gracilis)、赤馬陸（Nedyopus tambanus)等。 關於昆蟲，係例示如下：屬於缕尾目（Thysanura)之敏 梅衣魚（Ctenolepisma villosa Escherich)等；屬於直翅 目（Orthoptera)之洞總螽（cave cricket)、螻蛄（mole cricket)、黃臉油葫蘆（Teleogryllus emma)、東亞飛虫皇 (locusta migratoria)、沙漠飛蝗（Schistocerca gregaria)、蝗蟲（locust)等；屬於革翅目（Dermaptera) 之蠼螋（earwig)等；屬於蜚蠊目（Blattaria)之德國蜚蠊 (Blattella germanica)、黑胸大蠊（Periplaneta ful iginosa)、日本蜚蠊（Periplaneta Japonica)、美洲蜚 蠊（Periplaneta americana)等；屬於等翅目（Isoptera) 之曰本白蟻（Japanese subterranean termite)、台灣家白 蟻（Formosan subterranean termite)、小楹白蟻 (Incisitermes minor HAGEN)等；屬於喷蟲目（Psocoptera) 之嗜轰書_il(Liposcelis entomophilus Enderlein)、書益 (LiposcelisbostrychophilusBadonnel)等；屬於食毛目 (Mallophaga)之犬食毛5L(Trichodectes canis)、描蟲 (Fel icola subrostratus)等；屬於蟲目（Anoplura)之體兹 8 321673 201121419 (Pediculus humanus corporis)、陰蝨（Pthirus pubis)、 體兹（Pediculus humanus)等；屬於半翅目（Hemiptera)之 褐飛鼠（Nilaparvata lugens Stal)、黑尾葉蟬 (Nephotettix cincticeps)、溫室粉蝨（Greenhouse white fly)、桃蚜（Myzus persicae)、臭蟲（Cimex lectularius Linnaeus)、褐翅椿象（Halyomorpha halys)等；屬於鞘翅 目（Coleoptera)之皮橐（dermestid beetles)、黃守瓜 (Aulacophora femoralis)、玉米象（Sitophilus zeamais)、竹粉橐（Lyctus brunmeus)、日本蛛甲（Ptinus japonicus)、日本金龜（Popillia japonica Newman)等； 屬於蚤目（Siphonaptera)之猶蚤（cat f lea)、狗蚤（dog flea)、人蚤（human flea)等；屬於雙翅目（Diptera)之淡 色庫蚊（Culex pipiens pallens couguillett)、埃及斑蚊 (Aedes aegypti)、癌蚊屬（anopheles)、蚋科 (Simuliidae)、搖蚊（Chironomus)、蛾蚋科 (Psychodidae)、家繩（House fly)、采采繩（Glossina palpalis)、it(Tabanus trigonus)、食财繩亞科 (Syrphinae)等；屬於膜翅目（Hymenoptera)之，虎頭蜂屬 (Vespa)、長腳蜂屬（Polistes)、松綠葉蜂（Nesodiprion japonica Marlatt)、栗瘦蜂（Dryocosmus kuriphilus)、 曰本硬皮腫腿蜂（SclerQdermus nipponicus)、小黃家蟻 (Monomorium pharaonis)等；等。 關於顯現抗菌、防黴、防污、除草、楂"物呀?％調節、 經皮治療、防銹 '潤滑、抗結塊（anti-blocking)、表面活 9 321673 201121419 化以及抗靜電作用之可釋放性活性化合物，例示者為市售 可付之抗菌劑、防黴劑、防污劑、除草劑、植物生長調節 劑、經皮治療劑、防銹劑、潤滑劑、界面活性劑、抗靜電 劑等。 關於潤滑劑，例示者為直鏈C8-22脂肪酸、Cm脂族醇、 \乙醇C8-22月曰知醒胺、石夕_油（s ^ η c〇ne 〇 u )、松香 衍生物等。 關於抗靜電劑，例示者為C8 22脂肪酸甘油酉旨、山梨醇 酐脂肪酸酯、聚乙二醇酯等。 。關於防霧劑，有兩種類型之防霧劑：一種在室温（23 C)下王固體，而另一種在相同溫度下呈液體。關於固體防 霧劑，例示者為非離子界面活性劑。非離子界面活性劑之 實例包含：山梨醇酐脂肪酸酯類界面活性劑，例如山梨醇 酐單硬脂酸酯、山梨醇酐單棕櫚酸酯、山梨醇酐單蘿酸酯 以及山梨醇酐單二十八酸酯；甘油脂肪酸酯類界面活性 劑，例如甘油單月桂酸酯、甘油單棕櫊酸酯以及甘油單硬 月曰酸酯，聚乙二醇類界面活性劑，例如聚乙二醇單棕櫚酸 酯以及聚乙二醇單硬脂酸酯；烷基酚之環氧烷加成物；山 梨醇酐/甘油縮合物與有機酸之酯；以及胺類界面活性劑， 例如聚氧伸乙基烷基胺化合物，其包含聚氧伸乙基（2莫耳） 十八烷胺、聚氧伸乙基（2莫耳）十二烷胺、聚氧伸乙基（4 莫耳）十八烧如尊，聚氧伸乙基烧基胺化合物之脂肪酸酉旨， 其包含聚氧伸乙基（2莫耳）十八烷胺單硬脂酸酯、聚氧伸 乙基（2莫耳）十八烷胺二硬脂酸酯、聚氧伸乙基（4莫耳） 321673 10 201121419201121419 VI. Description of the Invention: TECHNICAL FIELD OF THE INVENTION The present invention relates to a polymer composition and a molded article formed from the polymer composition. [Prior Art] Since a molded article of various shapes can be obtained at a relatively low cost, a polymer composition containing an active compound (such as an insecticide) in a polymer and a molded article formed from the polymer composition have been It is known to the public and has been widely used in various fields. These moldings exhibit their function by evapotranspiration of the active compound or by leakage of the active compound onto the surface of the molded article, thereby releasing the active compound, also known as exudation (b 1 eedi ng) (see Patent Document 1). When the active compound used has low evapotranspiration properties, the compound will be difficult to release from the molded article by its evapotranspiration, and thus the compound is mainly released from the molded article by exudation. When the amount of the active compound retained in the molded article exceeds the saturation amount of the polymer (which is a supersaturation amount), bleeding will occur, and this is a supersaturated amount of the active compound (=the amount of the active compound added - the active compound The amount of saturation in the molded article) is a phenomenon of migration to the surface of the molded article over time. When the molded article is formed of a polymer composition containing an amount of the active compound exceeding the saturation amount, the active compound will bleed out to the surface of the molded article at any time. However, it is generally known that this rate of exudation varies significantly with the initial amount of active compound added, and this rate of exudation tends to decrease with time. On the other hand, when the molded article exhibits its action by "exuding the active compound", the time period during which the desired bleeding rate can be obtained is 321673 201121419 which is an indicator of the effective period of the molded article. Therefore, once the effective period of the molded article is determined, the initial addition amount of the releasable active compound (4) (10) active compound can be determined. In order to obtain a molded article which can be used for a long period of time, it is necessary to use a polymer composition containing an active compound in excess of the amount of the polymer saturated. However, the molded article formed by using the polymer composition containing the supersaturated amount of the active compound in the polymer causes a large amount of the active compound to bleed out before the use thereof, so that the bleeding rate cannot be maintained for the desired period of time. Patent Document 1: JP-A-6-315332 [Disclosed from the results of intensive studies by the inventors, it has been found that the use of a dilute hydrocarbon polymer composition containing a dilute-smoke polymer, an active compound, and a branched fatty acid can effectively prevent activity. The rate of exudation of the compound is reduced so that the amount of exudation of the active compound can be increased over a predetermined period of time. The present invention has been completed based on this finding. That is, the present invention provides a polymer composition comprising: parts by weight of an olefin-based polymer; and from 0.01 to 100 parts by weight of the branched-chain fatty acid per 100 parts by weight of the olefin-based polymer to 200 parts by weight of a releasable active compound. This month's progress is long: a molded article formed from the above polymer composition. According to the present invention, the decrease in the bleeding rate of the active compound can be prevented, so that a polymer composition capable of increasing the amount of exudation of the active compound for a predetermined period of time, and a molded article formed from the polymer composition can be provided. 321673 201121419 [Embodiment] The present invention provides a polymer composition comprising: 100 parts by weight of an olefin-based polymer; and 0.01 to 100 parts by weight of branched-chain fatty acid per 100 parts by weight of the olefin-based polymer And 0.01 to 200 parts by weight of the releasable active compound. The term "releasing property" in the "releasable active compound" of the present invention means that the active compound can be exuded from the molded article formed of the polymer composition and leaked to the surface of the molded article. Releasable active compounds are organic compounds which exhibit the following related effects: insect control, antibacterial, anti-mildew, antifouling, herbicidal, plant growth regulation, percutaneous treatment, anti-recording, lubrication, surface activation or anti- Electrostatic effect. These organic compounds may be used singly or in combination. As the releasable active compound, a compound selected from the group consisting of insect control agents, lubricants, antistatic agents, and antifogging agents is preferably used. 01重量份或。 The amount of the amount of the releasable active compound is preferably 0.01 parts by weight or 0.1 parts by weight. More, more preferably 0.1 parts by weight or more. Further, from the viewpoint of suppressing the viscosity of the obtained molded article, the amount of the releasable active compound added is preferably 200 parts by weight or less, more preferably 100 parts per 100 parts by weight of the olefin-based polymer. It is preferably 50 parts by weight or less by weight or less. When an insect control agent is used as an insect-resistant activity; a ground-permeable organic compound, the following insect control compounds can be used, for example, an insecticide, an insect 5 321673 201121419 growth regulator, an insect repellent, and the like. Compounds (i.e., synergists) which can be used to enhance the effectiveness of insect control agents can be used in combination. Examples of synergists include piperonyl butoxide, octachlorodipropyl ether, thiocyanoacetic isobornyl, N-(2-ethylhexyl)-bicyclo[2, 2, 1 ]-hept-5-ene-2,3-dicarboxyarsenine, N-(2-ethylhexyl)-1-isopropyl-4-indolyl ring [2, 2, 2] oct-5- Rare-2, 3-two ruminant imines, etc. Examples of the insecticide include a pyrethroid-based compound, an organophosphorus compound, an amino phthalate compound, a phenylpyrazole compound, and the like. Examples of pyrethroids include permethrin, aiethrin, d-allethrin, dd-allethrin, d-tetramethrin, Praiiethrin, cyphenothrin, d-phenothrin, d-resmethrin, empenthrin, fenvalerate, Esfenvaierate, fe叩ropathrin, cylonothrin, cyfluthrin, fenfenin (et〇; fenpr〇x), tralomethrin, Bening (esbi〇thrin), benfluthrin, teraiiethrin, deltamethrin, phen〇thrin, tefluthrin, bifenin (bifenthrin), cyfluthrin, Cyphen〇thrin, cypermethrin, _Cypermethrin, etc. Organophosphorus 321673 6 201121419 Examples of compounds include fenitr〇thi〇n, dichlorovos, naled, fenthi〇n, cyanophos, Taosson (chl〇rpyrif〇s), calclofos, salithi〇n, diazin〇n, etc. Examples of the amino phthalate compound include methoxydiazon, pr〇p〇xur, fenobucarb, carbaryl, and the like. Examples of the phenylpyrazole compound include fipr〇nil and the like. Examples of insect growth regulators include pyriproxfen, meth〇prene, hydroprene, diflubenzur〇n, cyromazine, and sino克(phen〇xycarb), lufenur〇n, etc. Examples of the insect repellent include diethyl toluamide, dibutyl phthalate, and the like. As the insect control agent, preferred is an insecticide, and more preferably a pyrethroid compound. More preferably, it is a pyrethroid compound which exhibits a vapor pressure of less than ^1〇_6 mmHg (mmHg) at 25 °C. With regard to these pyrethroid compounds, the examples are listed as chlorhexidine and chlorhexidine. Examples of insects which are controlled by the above insect control agents are Arthropoda, such as spiders, ticks and insects. Examples are as follows: Acridae, sylviarum, citrus red mite, Tyrophagus putrescentiae, etc.; belonging to the arachnid (Arachnjda) 321673 7 201121419 Atypus karshi, indoor phantom spider (Pholcus phalangioides), etc.; belonging to the genus Scutigeromorpha (Thereuopoda clunifera); belonging to the genus Chilopoda (Lithopolys asperatus), etc.; and Oxidus gracilis, Nedyopus tambanus, etc. belonging to the family Chilopoda, Polydesmoidea. As for the insects, the following are exemplified as: Ctenolepisma villosa Escherich belonging to the genus Thysanura; cave cricket, mole cricket, yellow face oil belonging to the Orthoptera Teleogryllus emma, locusta migratoria, Schistocerca gregaria, locust, etc.; belonging to the genus of the genus Dermaptera (earwig); belonging to the genus Blattaria Blattella germanica, Periplaneta ful iginosa, Periplaneta Japonica, Periplaneta americana, etc.; Japanese subterranean belonging to Isoptera Termite), Taiwanese termite (Formosan subterranean termite), Incisitermes minor HAGEN, etc.; belongs to the genus Psocoptera (Liscelis entomophilus Enderlein), Shuyi (Liposcelisbostrychophilus Badonnel), etc. Mallophaga dog hair 5L (Trichodectes canis), Deworm (Fel icola subrostratus), etc.; It belongs to the genus Anoplura 8 321673 201121419 (Pediculus humanus corporis), Pthirus pubis, Pediculus humanus, etc.; Hemiptera lugens Stal belonging to Hemiptera, black Nephotettix cincticeps, Greenhouse white fly, Myzus persicae, Cimex lectularius Linnaeus, Halyomorpha halys, etc.; belonging to the coleoptera (Coleoptera) Dermestid beetles), Aulacophora femoralis, Sitophilus zeamais, Lyctus brunmeus, Ptinus japonicus, Popillia japonica Newman, etc.; belonging to Siphonaptera Cat f lea, dog flea, human flea, etc.; Dixtera's Culex pipiens pallens couguillett, Aedes aegypti, Anopheles, Simuliidae, Chinonomus, Psychodidae, House fly, Glossina pal Palis), it (Tabanus trigonus), Syrphinae, etc.; belonging to the Hymenoptera, Vespa, Polistes, Nesodiprion japonica Marlatt), Dryocosmus kuriphilus, SclerQdermus nipponicus, Monomorium pharaonis, etc.; About the development of antibacterial, anti-mildew, anti-fouling, weeding, 楂 物 物 % % %% adjustment, transdermal treatment, rust-proof lubrication, anti-blocking, surface activity 9 321673 201121419 and antistatic effect Releasable active compound, exemplified by commercially available antibacterial agents, antifungal agents, antifouling agents, herbicides, plant growth regulators, transdermal therapeutic agents, rust inhibitors, lubricants, surfactants, antibiotics Electrostatic agent, etc. As the lubricant, an exemplary one is a linear C8-22 fatty acid, a Cm aliphatic alcohol, \ethanol C8-22, 曰 曰 胺 amine, Shi Xi _ oil (s ^ η c〇ne 〇 u ), a rosin derivative, and the like. The antistatic agent is exemplified by C8 22 fatty acid glycerin, sorbitan fatty acid ester, polyethylene glycol ester or the like. . With regard to antifogging agents, there are two types of antifogging agents: one is a solid at room temperature (23 C) and the other is a liquid at the same temperature. As the solid antifogging agent, a nonionic surfactant is exemplified. Examples of nonionic surfactants include: sorbitan fatty acid ester surfactants such as sorbitan monostearate, sorbitan monopalmitate, sorbitan monoling, and sorbitan mono Octadecyl ester; glycerol fatty acid ester surfactants, such as glycerol monolaurate, glycerol monopalmitate, and glycerol mono-hard phthalate, polyethylene glycol surfactants, such as polyethylene glycol Palmitate and polyethylene glycol monostearate; alkylene oxide adducts of alkyl phenols; esters of sorbitan/glycerol condensates with organic acids; and amine surfactants, such as polyoxyethylene Alkylamine compound comprising polyoxyethylene (2 mole) octadecylamine, polyoxyethylene (2 mole) dodecylamine, polyoxyethylidene (4 mole) The fatty acid of the polyoxyalkylene amide compound, which comprises a polyoxyethylene (2 mol) stearylamine monostearate, a polyoxyethylene (2 mol) Octadecylamine distearate, polyoxyethylene (4 mol) 321673 10 201121419
丁二玩胺硬脂酸酯等；以 肪酸胺’其包含聚氧伸乙基（2莫耳）酿胺硬脂酸醋等。 胺單蘿酸酯、聚氧伸乙基（2莫耳） 以及聚氧伸乙基烷基胺化合物之脂 在至溫下呈液體的防霧劑之實例包含Dicactam, such as amine stearate; and fatty acid amine, which comprises polyoxyethylene (2 mol), stearic acid, stearic acid vinegar, and the like. An example of an anti-fogging agent which is liquid at a temperature to a salt of an amine mono-arrose, a polyoxyethylidene (2 mol), and a polyoxyalkyleneamine compound.
·‘甘油類脂肪酸 ‘二甘油倍半油 四甘油三油酸 醋、六甘油五油_、四甘油單月桂酸g旨以及六甘油單月 ，以及山梨醇酐脂肪酸酯，例如山梨醇酐單油酸酯、 山梨醇酐二油酸酯以及山梨醇酐單月桂酸酯。 抗菌劑之實例包含：醇類，例如乙醇；已知之抗微生 物性活性成分，例如次氯酸鹽、氯胺、碘、過氧化物、 酚化合物、羥基苯甲酸、雙（羥基苯基）烷、8_羥基喹啉及 其衍生物、四級録相關化合物、松油化合物、胺基甲酸及 脲衍生物、環氧乙烷及環氧丙烷；以及已知之抗菌劑，例 如酚、鹵素化合物、四級銨化合物、胺、烷醇胺、硝基衍 生物本如化物、有機硫、硫-氮化合物、萘咬酮酸 (nalidixic acid)及其他喹諾酮（qUin〇i〇ne)叛酸' 硝基吱 喃以及磺醯胺。 抗真菌劑之實例除了包含前述已知之抗微生物性活性 成分外’復包含異噻唑酮類化合物以及此等異噻唑酮類化 合物之晶籠化合物。 關於防污劑’例示者為已知之防污劑。關於有機錫化 11 321673 201121419 合物’例示者為雙（三丁基錫）氧化物、氣化三丁基錫、氟 化三丁基錫、乙酸三丁基錫、菸鹼酸三丁基錫、凡賽堤酸 三 丁基錫（tributyltin versatate)、雙（三丁基錫）α，α， —二溴丁二酸鹽、氫氧化三苯基錫、菸鹼酸三苯基錫、凡赛 堤酸三苯基錫、雙（三笨基錫）α，α，_二溴丁二酸鹽、雙（三 苯基錫）氧化物、乙酸三苯基錫、三苯基錫二甲基二硫胺甲 酸鹽等。 關於除草劑’例示者為三畊類化合物，例如草脫淨 (atrazin)以及滅必淨（metribuzin);腺類化合物，例如可 奪草（fluometuron)以及異丙隆（isoproturon);經基苯甲 腈類化合物，例如溴笨腈（bromoxynil)以及破苯腈 (1(^71^1);2,6-二硝基苯胺類化合物，例如施得圃 (pendimethalin)以及三福林（trifluraline);芳氧基-烷 酸類化合物，例如2, 4-D、汰克草（dicamba) '氟氯比 (fluoroxypyr)以及美肯寧（mecoprop);磺醯脲類化合物， 例如免速隆（乜6115111于111*011-111€1±71)、甲石黃隆 (metsulfuron-methyl)、煙嘧磺隆（nicosuifuron)、氟嘧 石黃隆（口1*丨111丨3111{111〇11-11161：1^1)以及環石黃隆 (cyclosulfamuron);咪唑琳酮（imidazolinone)類化合 物，例如依滅草（imazapy 1)、滅草啥（imazaqui η)以及σ米草 煙（imazethapyr);雙草醚（bispyribac sodium).;必賽貝 (bisthiobac-sodium);亞喜芬（acifluorfen sodium);曱 磺草胺（suHentrazone);巴拉刈（paraquat);唑嘧磺草胺 (flumetsulam);氟胺磺隆（triflusulfuron-methyl);芬 12 321673 201121419 殺草（fenoxaprop-p-ethyl) ; 丁基賽伏草（cyhalofop 1311七71);11比氟草胺（(1丨{11^611丨0&11);氟草敏 (norflurazon);異曙氟草（isoxaflutole);固殺草 (glufocinate ammonium);嘉構塞（glyphosate);本達隆 (bentazone);殺丹（benthiocarb);滅芬草（mefenaset); 除草靈（propanil);陸替邁（flutiamide);等。 關於植物生長調節劑，例示者為順丁烯二醯肼（ma 1 e i c hydrazide)、克美素（chlormequat)、益收生長素 (ethephon)、激勃素（gibberellins)、曱哌（mepiquat chloride)、噻苯隆（thidiazuron)、依鈉素（inabenfide)、 巴克素（paclobutrazol)、稀效π坐（uniconaz〇i)等。 關於經皮治療劑’例示者為已知之含費洛蒙 (pheromone)劑、止痛樂、終驗（nic〇tine)等。 關於銹蝕控制劑，例示者為苯并***、二環己胺亞硝 酸鹽、甲苯基***等。 可釋放性活性化合物可呈可釋放性活性化合物撐體 (support)之形式使用，該可釋放性活性化合物撐體係藉由 使可釋放性活性化合物以留存、運載、浸潰、浸滲、注射、 吸附或吸收之方式來處理撐體而獲得。關於撐體，係使用 可留存、運载、吸收、吸附、浸潰、浸滲或注射可釋放性 活性化合物者。此等撐體之實例包含氧化矽類化合物、沸 石、黏土礦物、金屬氧化物、雲母、水滑石、有機撐體等。 關於氧化矽類化合物，例示者為非晶形氧化矽以及結晶形 氧化矽。氧化矽類化合物之實例包含粉末狀水合氧化矽、 13 321673 201121419 細料水合氧化石夕、酸性黏土、石夕藻土、石英、· 'Glycerol fatty acid' diglycerin sesquiole oil tetraglycerine trioleate vinegar, hexaglycerol pentahydrate _, tetraglycerol monolauric acid g and hexaglycerol single month, and sorbitan fatty acid esters, such as sorbitan Oleic acid ester, sorbitan dioleate, and sorbitan monolaurate. Examples of antibacterial agents include: alcohols such as ethanol; known antimicrobial active ingredients such as hypochlorite, chloramine, iodine, peroxides, phenolic compounds, hydroxybenzoic acid, bis(hydroxyphenyl)alkane, 8-hydroxyquinoline and its derivatives, quaternary related compounds, pine oil compounds, urethane and urea derivatives, ethylene oxide and propylene oxide; and known antibacterial agents such as phenols, halogen compounds, four Ammonium compounds, amines, alkanolamines, nitro derivatives, such as organic compounds, organic sulfur, sulfur-nitrogen compounds, nalidixic acid and other quinolones (qUin〇i〇ne) And sulfonamide. Examples of the antifungal agent include, in addition to the aforementioned known antimicrobial active ingredient, a composition comprising an isothiazolone compound and a cage compound of such an isothiazolone compound. The antifouling agent is exemplified by known antifouling agents. About organotinization 11 321673 201121419 The compound 'exemplified is bis(tributyltin) oxide, tributyltin vaporized, tributyltin fluoride, tributyltin acetate, tributyltin niacin, tributyltin versitine (tributyltin versatate) ), bis(tributyltin)α,α,-dibromosuccinate, triphenyltin hydroxide, triphenyltin niacin, triphenyltin, vanadine, bis(triphenyl) α,α,_dibromosuccinate, bis(triphenyltin) oxide, triphenyltin acetate, triphenyltin dimethyldithiocarbamate or the like. Examples of herbicides are three-till compounds, such as atrazin and metribuzin; glandular compounds such as fluometuron and isoproturon; Nitrile compounds, such as bromoxynil and decatezonitrile (1 (^71^1); 2,6-dinitroaniline compounds, such as pendimethalin and trifluraline; aryl oxygen Alkanoic acid compounds, such as 2, 4-D, dicamba 'fluoroxypyr and mecoprop; sulfonylureas, such as sedatives (乜6115111 at 111*) 011-111€1±71), metsulfuron-methyl, nicosuifuron, fluorosulfurite huanglong (mouth 1*丨111丨3111{111〇11-11161:1^1) And cyclosulfamuron; imidazolinone compounds, such as imazapy 1, imazaqui η, and imazethapyr; bispyribac sodium ); bisthiobac-sodium; acifluorfen sodium; suHentrazone; Paraquat); flumetsulam; triflusulfuron-methyl; fen 12 321673 201121419 fenoxaprop-p-ethyl; butylalofop 1311 7 71; 11 ratio Fluroxylamine ((1丨{11^611丨0&11);norflurazon;isoxaflutole; glufocinate ammonium; glyphosate; Bendarone (bentazone); benthiocarb; mefenaset; propanil; flutiamide; etc. Regarding plant growth regulators, the example is maleic acid (ma 1 Eic hydrazide), chlormequat, ethephon, gibberellins, mepiquat chloride, thidiazuron, inabenfide, paclobutrazol ), thin π sitting (uniconaz〇i) and so on. The percutaneous therapeutic agent 'exemplary' is a known pheromone-containing agent, painkiller, nic〇tine, and the like. As the rust control agent, exemplified are benzotriazole, dicyclohexylamine nitrite, tolyltriazole and the like. The releasable active compound can be used in the form of a releasable active compound which retains, carries, impregnates, infiltrates, injects, Obtained by treating or adsorbing the support. Regarding the support, those which can retain, carry, absorb, adsorb, impregnate, infiltrate or inject a releasable active compound are used. Examples of such supports include cerium oxide compounds, zeolites, clay minerals, metal oxides, mica, hydrotalcite, organic supports, and the like. As the cerium oxide compound, an amorphous cerium oxide and a crystalline cerium oxide are exemplified. Examples of cerium oxide compounds include powdered hydrated cerium oxide, 13 321673 201121419 fine hydrated oxidized oxidized stone, acid clay, shixia earth, quartz,
於彿石’係使用A型彿石、絲光沸石等。關㈣土礦物 係使用蒙脫石（montmoril〇nite)、皂石、貝得石S ==lte)、膨土、高嶺石' 禾樂石㈤丨㈣伽）、透輝 撖热球粒卩貞石（祕仙）、狄克石（Mite)、㉔高嶺石 、伊利石⑴me)、絹雲母等。關於金屬氧化 用氧化辞、氧化鎂、氧化紹、氧化鐵、氧化銅、 =專。關於雲母，係使用雲母，石等。關於水滑石， =滑石、膨潤石L有麟體，錢財炭類（木 =、泥厌、泥煤等）、聚合物珠粒（微晶纖維素、聚笨乙烯 =、丙烯酸醋珠粒1基丙稀酸醋珠粒、聚乙稀醇珠粒 寻）以及其父聯聚合物珠粒。除此之外，例示者尚有珍珠 岩、石膏、陶瓷、火山岩等。 / _本發明職用之雜系聚合物，例示者為乙稀系 U物、丙烯系聚合物、丁烯系聚合物及4-甲基+戊烯 =合物’以及此等聚合物之修飾產物、阜化產物與氯化 =關於烯烴系聚合物，可組合使用選自上述聚合物之 兩種或更多種聚合物。 、關於乙烯系聚合物，例示者為包含乙烯系單體單元作 單元之聚合物（轉絲合物之财單體料為⑽ 合物通常含有5〇莫耳％或更多的乙婦系單 體早几）’例如乙埽均聚物 '乙婦1,烴共聚物、乙烯- 醋共聚物、乙烯—丙稀酸共聚物、乙婦-丙婦酸醋 4物、乙烯-甲基丙稀酸共聚物、乙稀一甲基丙稀酸酉旨共 321673 14 201121419 二 關於乙稀均聚物，係使用 一聚物之二聚广:於乙烯- 丙婦、卜丁歸、卜戊婦、卜者=-★烴，例如 烯、卜癸烯、卜十1 卜庚烯、1-辛烯、卜壬 關於乙稀-α“ :基+戊稀、4-甲基-己稀等。 稀™聚物乙==為乙烯，共聚物、乙 物、乙烯-卜丁稀+己烯共聚物等。~辛如共1 ::丙烯聚合物，例示者為包含丙烯系單體單元作 2要早破聚合物（以構成聚合物之所有單體單 ⑽ 、耳％計，該聚合物通常含有50莫 法^ 體單元），例如丙煤均聚 4更夕的丙缔系單 丁嫌心你缔-乙稀共聚物、丙稀+ y導乙稀n共聚物、丙稀-環狀稀烴共 ^寺關於丙稀-α一燦烴共聚物之1婦煙，例示者 C4—C20 (2 -婦烴，例如卜丁说 ’·、、 ^例如I 了烯'卜戊烯、卜己烯、卜庚烯、 甲=:。、—十二烯、一戊“ 稀烴系聚合物較佳為乙稀系聚合物，更佳為 烯烴共聚物。 由改善所得模製品之外觀的觀點來看，婦烴系聚合物 之炫體流動速率（melt fl0Wrate，_)較佳為〇 . i公克口⑷ 八〇分鐘（min.)或更高，更佳為〇.3g/1〇 rain.或更高，i 更佳為G. 5 g/lG min·或更高。再者，由改善所得模製品 之機械強度的觀點來看，烯烴系聚合物之熔體流動2 = 321673 15 201121419 (MFR)較佳為20 g/l〇 min.或更低，更佳為i〇 g/i〇 fflin 或更低，又更佳為5 g/10 min·或更低。就此點而言，丙 烯系聚合物之MFR係根據JISK7210-1995所制訂之方法於 230°C於21.18 N之荷重（load)進行測量；而丙烯系聚合物 以外的其他聚合物（亦即，乙烯系聚合物以及丁烯系聚合物） 之MFR係於I90t於21. 18 N之荷重進行測量。 由促進可釋放性活性化合物滲出之觀點來看，乙烯系 聚合物之密度較佳為980公斤/立方公尺（kg/m3)或更低丫 更佳為970 kg/m3或更低，又更佳為96〇 kg/m3或更低。再 者，由改善所得模製品之剛性的觀點來看，乙烯系聚合物 之岔度較佳為870 kg/m3或更高，更佳為875 kg/m3或更高， 又更佳為880 kg/m3或更高。就此點而言，該密度係藉由下 述方法測量：亦即，根據JISK676〇_1995所制訂之方法使 待測量之測試片退火（anneal)，接著再根據JIS K7112_ 1980所述方法中的方法Α所制訂之程序測量其密度。 烯烴糸聚合物之製造係於已知之烯烴聚合用催化劑 (例如，齊格勒-納塔催化劑（Ziegler_Natta cataiyst)、 鉻類催化劑、二茂金屬（metall〇ceneMM催化劑、自由基聚 合作用催化劑、有機金屬化合物等）的存在下，藉由已知之 聚合方法（例如，溶液聚合、漿體聚合（slurry polymerization)、氣相聚合、高壓聚合等）製造。聚合方 法可為批次型或連續型，或可為兩步驟或多步驟聚合。 本發明所使用之支鏈脂肪酸為具有至少一個羧基以及 至少-個與3個或更多個碳原子鍵結的碳原子之物質。支 321673 16 201121419 鏈脂肪酸較佳為C4-3。支鏈脂肪酸，更佳為C8-28支鏈脂肪酸。 脂肪酸之分支數並無限制。支鏈脂肪酸之實例包含異丁 酸、異戊酸、異己酸、異辛酸、異癸酸、異十二酸、異十 四酸、異十六酸、異硬脂酸、異二十酸、異二十二酸、異 二十四酸等。可釋放性活性化合物之滲出量係藉由添加支 鏈脂肪酸而增加。支鏈脂肪酸之添加量可依據所欲之可釋 放性活性化合物的滲出量以及所欲之滲出時間期進行調 整。由增加滲出量作用的觀點來看，相對於每100重量份 之烯烴系聚合物，支鏈脂肪酸之添加量較佳為0. 01重量份 或更多，更佳為0.1重量份或更多。再者，由抑制所得模 製品之黏性的觀點來看，相對於每100重量份之烯烴系聚 合物，支鏈脂肪酸之添加量較佳為100重量份或更少，更 佳為50重量份或更少，又更佳為30重量份或更少。 於本發明中，支鏈脂肪酸係不同於可釋放性活性化合 物之化合物。 本發明之聚合物組成物除了含有支鏈脂肪酸及可釋放 性活性化合物外，還可視需要含有其他添加劑。 本發明之聚合物組成物可藉由已知方法將烯烴系聚合 物、支鏈脂肪酸以及可釋放性活性化合物溶融及捏合而獲 得。例如，使用播製機、滾墨成形機（rol 1 molding machine) 或揑合機等來熔融及捏合預先製備之烯烴系聚合物、支鏈 脂肪酸與可釋放性活性化合物的混合物；將烯烴系聚合 物、支鏈脂肪酸以及可釋放性活性化合物個別饋送至擠製 機、滚壓成形機或揑合機等，然後再進行熔融及混合；將 17 321673 201121419 預先製備之支鏈脂肪酸與可釋放性活性化合物的混合物以 及烯烴系聚合物饋送至擠製機、滾壓成形機或揑合機等， 然後再進行熔融及混合；或者將預先製備之烯烴系聚合物 與支鏈脂肪酸的混合物以及可釋放性活性化合物個別饋送 至擠製機、滾壓成形機或揑合機等，然後再進行熔融及捏 合。在使用擠製機進行熔融-捏合的情況下，可使用添加裝 置（例如，側邊擠製機或進料器）自該擠製機之中間位置注 入炫融混合物。 可使用可釋放性活性化合物與支鏈脂肪酸作為與聚合 物混合之母料，且此母料可與烯烴系聚合物熔融及捏合， 藉以提供本發明之聚合物组成物。尤佳者為使用可釋放性 活性化合物作為與聚合物混合之母料。 關於作為母料基質之聚合物，例示者為烯烴系聚合 物，例如乙烯系聚合物、丙烯系聚合物、丁烯系聚合物及 4-甲基-1-戊烯系聚合物，以及該等聚合物之修飾產物、皂 化產物與氫化產物。其較佳實例包含高密度聚乙稀、直鏈 低密度聚乙烯、直鏈極低密度聚乙烯、直鏈超低密度聚乙 烯、高壓處理之低密度聚乙烯、乙烯系聚合物如乙烯-乙酸 乙烯酯共聚物等、氫化丁二稀系聚合物等。 當使用母料來製備聚合物組成物時，相對於本發明聚 合物組成物中所含每100重量份之烯烴系聚合物，該母料 之添加量通常少於5 0重量份。由改善成本效益的觀點來 看，母料之添加量較佳為2 0重量份或更少，更佳為10重 量份或更少。 18 321673 201121419 、關於聚σ物組成物之成形方法，例示者為已知之成形 方法例如射出成形、擠製成形、模壓成形、以及凝塑成 t(slush molding)(用於粉末）。除此之外，亦可依據最終 用述適田地選用習知用於稀烴系、聚合物之任何製程，例如 多層撥製成形、多色射出成形、複合纺絲（composite spmmng)或播製積層（extrusi〇niaminate)成形；該最終 用迷換。之為·改善聚合物組成物於使用時之動態物理 性貝口:增加可釋放性活性化合物於所得模製品表面之濃 度或文σ t 5物組成物之成形性（moidabiiHy)。於所得 模製σσ中由本發明聚合物組成物所形成之層可依據最終 用途設置於任何位置。 由本發明聚合物組成物成形而得之模製品的實例包 含：薄膜、板片、壁紙、窗簾、地板材料、填充材料、軟 嘗、乍Τ、官件、導管、袋、帳蓬、草坪、商店窗簾（此叩_ curtains)、百葉窗、電線、電纜、護套、絲線（fil⑽ent)、 纖維、網（蚊帳、紗窗、防蟲網等）、紗線、繩索、濾材、 地毯、鞋、袋、衣服、電子設備、電氣設備、家用電器、 商業械器、運輸工具、運.|^基備被.物5滋^思^县^惠.·為威箱、 房屋材料、房屋部件以及寵物用具如狗舍、塑1子、薄板、 頸圈及標籤。 於上述模製品中，本發明之效用在拉伸型模製品 (drawn molded article)中尤其顯著。本文所使用之術語 「拉伸」係意指藉由巴離赞態喊熔融 狀態之模製品進行單軸或雙軸拉伸。例如，在絲線之成形 321673 201121419 ^中:係對㈣製機所播製之模製品進行拉引（PU⑴並 ~部以士成粗絲線’然後使該粗絲線通過熱水洛，接著再 以高於^之㈣料的速率騎拉Lx拉伸該絲線。 /列如，在早轴拉伸之情況下，係使用軋輕以i公尺/ 秒鐘On/敗）之旋轉速率㈣來自㈣機之模製品，最後 躲用軋報以1Gm/seG，之旋轉速率使該模製品形成樣 〇口在此If况下’拉伸比率^ 1〇。在雙轴拉伸之情況下， 拉伸比率為模製品之各個截面積於拉伸前與拉伸後所測得 的比率纟上述之絲線製造過程中，係使模製品通過位於 各個軋輕（各個純之拉引速率彼此不同）之間的熱水洛 等，以便將熱施加於模製品，而續高之拉伸比率拉伸該 模製品。較高之拉伸比率可支持下述作用：藉由添加支鍵 脂肪酸而增加可懸性活性化合物之滲出量。㈣品之拉 伸比率較佳為2或更高，更佳為4或更高，又更佳為6或 更高。過高之拉伸比率會導致較小之斷裂伸長率 eXtenSi〇n)以及較高之楊氏模數（Young’s modulus)。因 此，由所得絲線之撓性與延錄的觀點來看 ，拉伸比率較 ，為50或更低’更㈣30或更低，X更佳$20或更低， 最佳為15或更低。上述拉伸步驟並不需要與擠製於同—線 上進行亦即’可獨立進行單獨之拉伸步驟，且若有後續 步驟，此拉伸步驟可在之前進行。 本發明之聚合物組成物具有優異之炼融纺絲（melt_ spinning)性質以及充份之熔融擠製性（meit_ extrudabiHty)，因此較佳係用於製造絲線如多絲線 321673 20 201121419 (mi lti fi lament)及單絲線（monof i lament)。本發明之聚合 物組成物更佳係用於製造單絲線。由此聚合物組成物成形 之絲線於加熱下具有優異之拉伸性且具有充分之機械強 度。當使用此聚合物組成物製造絲線時，可以較高之出料 速率（discharge rate)對該聚合物組成物進行播製及纺 絲，因此可於單步（one-step)拉伸操作中高度地拉伸所得 之絲線。所以，可以較低成本製造絲線。 關於將本發明之聚合物組成物成形為絲線之方法，係 使用已知之成形方法，例如熔融紡絲法或（直接）紡絲/拉伸 法等。實際上，係使用擠製機等將該聚合物組成物炫融， 並經由齒輪泵自模具喷嘴擠製該熔融之聚合物組成物，以 形成聚合物組成物線（strand);然後拉引該炫融播製之線 狀聚合物組成物，再以紡絲用之冷卻介質如水或空氣將其 冷卻；接著視需要再於加熱下拉伸所得之絲線，進行熱處 理並以油塗覆，然後纏繞起來。 絲線之截面形狀為例如圓形、橢圓形、三角形、矩形、 六角形或星形。 實施例 後文中’將藉由實施例與比較例進一步說明本發明。 於實施例及比較例中，係根據下列方法測量物理性質。 (1) 熔體流動速率（MFR，單位為g/10 mins.) 熔體流動速率係根據JISK7210-1995所制訂之方法於 19 0 C，21. 18 N之荷重進行測量。 (2) 密度（單位為kg/m3) 321673 21 201121419 密度係根據JIS K7112-1980所描述之方法中的方法A 所制訂之程序測量。待測量之測試片係根據JIS K676〇-1995所制訂用於低密度聚乙烯之方法進行退火。 實施例1 (1) 製備可釋放性活性化合物撑體 使用昆蟲防治劑百滅寧（Eksmin® ’由Sumitomo Chemical Company，Limited製造）作為$釋放性活性化合 物。將抗氧化劑2, 6-二-第三丁基_4_甲基紛（後文中稱為 AO-1 )(1. 5重量份）溶於百滅寧（51重量份）中。接著’攪拌 百滅寧與A0-1之混合物（52. 5重量份）旅與非晶形氧化矽 撐體（Porous Silica®，由 Suzuki-Oil C〇.，Ltd.製造） (47. 5重量份）（亦即，相對於每100重量份之百滅寧為93. 1 重量份）混合，以獲得可釋放性活性化合物撑體。 (2) 製備聚合物組成物 關於烯烴系聚合物，係使用高密度聚乙烯顆粒 (HI-ZEX® 440M，由 PRIME POLYMER 製造；MFR= 〇.9 g/l〇 mins.;密度= 948 kg/m3)(100重量份）與高壓處理之低密 度聚乙烯顆粒（Sumikathene®G803,由 Sumitomo Chemical Company, Limited製造）（後文中稱為LD)(9· 8重量份）的 混合物（後文中，此混合物稱為烯烴系聚合物混合物）。 絲線之聚合物組成物係藉由下述方式製備：於大約150 °C，使用班布里混煉機（Banburymixer)熔融及捏合烯烴系 聚合物混合物（100重量份）、抗氧化劑（亦即，正十八基-3-(3, 5-二-第三丁基-4-經基苯基）丙酸酯）（Irganox® 22 321673 201121419 1076 ’ 由 Ciba Specialty Chemicals κ. κ.製造）（〇. 〇13 重 里伤）、可釋放性活性化合物撐體（4. 4重量份）以及2-庚基 十一酸（後文中稱為異硬脂酸1)(1.4重量份）。 (3) 製備單絲線 使用八有模具（s玄模具具有4個1 必的洞）之2 〇 mm Φ擠製機，將絲線用之聚合物組成物通過該模具（設定為 200 C ’出料速率為〇. 6公斤/小時（kg/hr))進行撥製。以 14 a尺/刀釦（m/min)之線速率（1丨此印杜廿）拉引所得之聚 合物組成物之線’並使其通過熱水浴，接著再以112 m/min 之速率拉引··亦即，拉伸比率為8。藉此獲得細度為測 丹尼（denier)之單絲線。 (4) 測量滲出量 將所彳于之單絲線存放於恆溫室（設定為23。〇中， 2別於3天後、7天後、14天後、28天後以及％天後取 出，每次都使料酮清洗單絲線之表面，以移轉 清洗用之丙嶋藉由吹送氮氣而㈣；接著使用含有5〇 PPm+碟酸三苯§旨作為内標準品之乙醇對照百滅寧之 並藉由氣相層析法測定百滅寧之滲出量。 使用氣相層析法之測量係於下列條件下進行： 注射量：1微升（# 1) 管柱.毛細管柱DB-1 (县声训八, 〔長度30公尺(m)’内徑〇 25毫 未（mm)，厚度0 25微米（#m)) 偵測器：氫焰游離偵測器（fid)A Buddha stone, mordenite, etc. are used in the Yufo stone. Guan (4) soil mineral system using montmoril 〇nite, saponite, beide stone S == lte), bentonite, kaolinite 'hele stone (five) 丨 (four) gamma), diarrhea hot granules Stone (Secret), Dickey (Mite), 24 kaolinite, illite (1) me), sericite, etc. About metal oxidation Oxidation, magnesium oxide, oxidation, iron oxide, copper oxide, = special. Regarding mica, mica, stone, etc. are used. About hydrotalcite, = talc, bentonite L has a body, money charcoal (wood =, mud, peat, etc.), polymer beads (microcrystalline cellulose, polystyrene =, acrylic vinegar beads 1 base Acetate vinegar beads, polyethylene glycol beads) and their parent polymer beads. In addition, the examples include pearlite, gypsum, ceramics, and volcanic rocks. / _ The heteropolymer of the present invention is exemplified by ethylene U, propylene, butene, and 4-methyl + pentene = and modification of these polymers Product, Deuterated Product, and Chlorinated = Regarding the olefin-based polymer, two or more polymers selected from the above polymers may be used in combination. The vinyl polymer is exemplified by a polymer containing a vinyl monomer unit as a unit (the monomer of the transducted compound is (10), which usually contains 5 〇 mol% or more. Early in the body) 'e.g., acetamidine homopolymer' 乙妇1, hydrocarbon copolymer, ethylene- vinegar copolymer, ethylene-acrylic acid copolymer, 乙妇-propyl vinegar 4, ethylene-methyl propylene Acid copolymer, ethylene methacrylate, 321673 14 201121419 2 About ethylene homopolymer, the use of a polymer of dimerization: in ethylene - Bing, Bu Dinggui, Bu Wu,卜 =- ★ hydrocarbons, such as alkenes, decenes, pexiene, heptene, 1-octene, dip, about ethylene-α ": ketone + pentane, 4-methyl-hexene, etc. TM polymer B == is ethylene, copolymer, ethyl, ethylene-butadiene + hexene copolymer, etc. ~ Xin Rujia 1 :: propylene polymer, exemplified by containing propylene monomer unit for 2 Prematurely break the polymer (to all the monomers (10) and ear % of the polymer, the polymer usually contains 50 moles of unit), for example, the homopolymerization of polypropylene - Ethylene copolymer, propylene + y-diethylene n-copolymer, propylene-ring-difficult hydrocarbons, a temple of propylene-α-canthene copolymer, 1 case, C4-C20 (2 - The hydrocarbon hydrocarbons, for example, Bu Ding said that '··, ^, for example, I have aene, a hexene, a heptene, a hepene, a pentane, a pentane, a dilute hydrocarbon polymer, preferably The ethylene polymer, more preferably an olefin copolymer. From the viewpoint of improving the appearance of the obtained molded article, the glare flow rate (melt fl0Wrate, _) of the hydrocarbon polymer is preferably 〇. i gram mouth (4) Eight minutes (min.) or higher, more preferably 〇.3g/1〇rain. or higher, i is more preferably G. 5 g/lG min· or higher. Furthermore, the molded article obtained by improvement From the viewpoint of mechanical strength, the melt flow of the olefin-based polymer 2 = 321673 15 201121419 (MFR) is preferably 20 g/l 〇 min. or lower, more preferably i 〇 g / i 〇 fflin or more. Low, and more preferably 5 g/10 min· or lower. In this regard, the MFR of the propylene-based polymer is measured at 230 ° C at a load of 21.18 N according to the method established by JIS K7210-1995. And the propylene polymer The MFR of the other polymers (i.e., the vinyl polymer and the butene polymer) is measured at a load of I18t of 21.18 N. From the viewpoint of promoting exudation of the releasable active compound, ethylene polymerization The density of the substance is preferably 980 kg/m 3 or less, more preferably 970 kg/m 3 or less, still more preferably 96 〇 kg/m 3 or less. From the viewpoint of the rigidity of the obtained molded article, the vinyl polymer preferably has a twist of 870 kg/m3 or more, more preferably 875 kg/m3 or more, and still more preferably 880 kg/m3 or more. . In this regard, the density is measured by the following method: that is, the test piece to be measured is annealed according to the method defined in JIS K676〇_1995, and then the method according to the method described in JIS K7112-1980 The procedure established by Α measures its density. The olefin oxime polymer is produced by a known catalyst for olefin polymerization (for example, Ziegler-Natta cataiyst, chromium catalyst, metallocene (metall〇cene MM catalyst, radical polymerization catalyst, organic metal) In the presence of a compound or the like, it is produced by a known polymerization method (for example, solution polymerization, slurry polymerization, gas phase polymerization, high pressure polymerization, etc.) The polymerization method may be batch type or continuous type, or may be Polymerization in two or more steps. The branched fatty acid used in the present invention is a substance having at least one carboxyl group and at least one carbon atom bonded to 3 or more carbon atoms. Support 321673 16 201121419 Preferably, the chain fatty acid It is a C4-3 branched fatty acid, more preferably a C8-28 branched fatty acid. The number of branches of the fatty acid is not limited. Examples of branched fatty acids include isobutyric acid, isovaleric acid, isohexanoic acid, isooctanoic acid, isodecanoic acid. , isododecanoic acid, isoletetradecanoic acid, isohexadecanoic acid, isostearic acid, isoicosuccinic acid, isoicosic acid, isotetradecanoic acid, etc. Releasable active compound The amount of exudation is increased by the addition of branched fatty acids. The amount of branched fatty acid added can be adjusted according to the amount of exudation of the desired releasable active compound and the desired period of exudation. From the viewpoint of increasing the amount of exudation The amount of the branched fatty acid added is preferably 0.01 parts by weight or more, more preferably 0.1 parts by weight or more per 100 parts by weight of the olefin-based polymer. Further, by suppressing the obtained molded article From the viewpoint of viscosity, the amount of the branched fatty acid added is preferably 100 parts by weight or less, more preferably 50 parts by weight or less, and still more preferably 30% per 100 parts by weight of the olefin-based polymer. In the present invention, the branched fatty acid is a compound different from the releasable active compound. In addition to the branched fatty acid and the releasable active compound, the polymer composition of the present invention may optionally contain other The polymer composition of the present invention can be obtained by melting and kneading an olefin polymer, a branched fatty acid, and a releasable active compound by a known method. For example, a boring machine, a rol 1 molding machine, or a kneader to melt and knead a previously prepared olefin-based polymer, a mixture of a branched fatty acid and a releasable active compound; and an olefin-based polymer, a branched chain The fatty acid and the releasable active compound are individually fed to an extruder, a roll forming machine or a kneader, etc., and then melted and mixed; a mixture of branched fatty acids and releasable active compounds and olefins prepared in advance by 17 321 673 201121419 The polymer is fed to an extruder, a roll forming machine or a kneader, etc., and then melted and mixed; or the previously prepared mixture of the olefin-based polymer and the branched fatty acid and the releasable active compound are individually fed to the extrusion A machine, a roll forming machine, a kneader, etc., followed by melting and kneading. In the case of melt-kneading using an extruder, an additive (e.g., side extruder or feeder) may be used to inject the smelt mixture from the middle of the extruder. A releasable active compound and a branched fatty acid may be used as a masterbatch mixed with the polymer, and the masterbatch may be melted and kneaded with the olefin-based polymer to provide the polymer composition of the present invention. It is especially preferred to use a releasable active compound as a masterbatch for mixing with the polymer. Examples of the polymer as the masterbatch matrix include olefin polymers, such as ethylene polymers, propylene polymers, butene polymers, and 4-methyl-1-pentene polymers, and the like. A modified product of a polymer, a saponified product, and a hydrogenated product. Preferred examples thereof include high density polyethylene, linear low density polyethylene, linear low density polyethylene, linear ultra low density polyethylene, high pressure treated low density polyethylene, vinyl polymer such as ethylene-acetic acid. A vinyl ester copolymer or the like, a hydrogenated butyl diene polymer or the like. When the master batch is used to prepare the polymer composition, the amount of the master batch added is usually less than 50 parts by weight per 100 parts by weight of the olefin-based polymer contained in the polymer composition of the present invention. The amount of the master batch added is preferably 20 parts by weight or less, more preferably 10 parts by weight or less, from the viewpoint of improvement in cost effectiveness. 18 321673 201121419 A method of forming a poly-sigma composition is exemplified by known forming methods such as injection molding, extrusion molding, press molding, and gel formation (for powder). In addition, any process known as a dilute hydrocarbon system or a polymer may be selected according to the final description, such as multi-layer forming, multi-color injection molding, composite spmmng or broadcast layering. (extrusi〇niaminate) forming; the final use of the fan. This is to improve the dynamic physical properties of the polymer composition at the time of use: increase the concentration of the releasable active compound on the surface of the obtained molded article or the formability of the composition of the composition (moidabiiHy). The layer formed of the polymer composition of the present invention in the obtained molded σσ can be placed at any position depending on the end use. Examples of molded articles obtained by molding the polymer composition of the present invention include: films, sheets, wallpapers, curtains, flooring materials, filling materials, soft taste, enamel, official parts, ducts, bags, tents, lawns, shops Curtains (curtains), blinds, wires, cables, sheaths, wires (fil(10)ent), fibers, nets (mosquito nets, screens, insect nets, etc.), yarns, ropes, filters, carpets, shoes, bags, clothes , electronic equipment, electrical equipment, household appliances, commercial machinery, transportation, transportation.|^基备被.物5滋^思^县^惠.· for the box, housing materials, house parts and pet equipment such as dogs House, plastic 1 piece, sheet, collar and label. Among the above molded articles, the effects of the present invention are particularly remarkable in a drawn molded article. As used herein, the term "stretching" means uniaxially or biaxially stretching by molding a molded article in a molten state. For example, in the forming of the wire 321673 201121419 ^: the molded article (4) and the part of the machine is drawn (PU (1) and ~ part of the wire into a thick wire] and then the thick wire through the hot water, and then high At the rate of (4) material, pull the Lx to stretch the wire. / Column, for example, in the case of early axis stretching, use the rolling speed to i meters / second On / defeat) The rotation rate (four) from (four) machine The molded article finally uses the rolling rate at a rotation rate of 1 Gm/seG, and the molded article is formed into a sample mouth under the condition of 'stretching ratio ^ 1 〇. In the case of biaxial stretching, the stretching ratio is the ratio of each cross-sectional area of the molded article measured before and after stretching. In the above-mentioned yarn manufacturing process, the molded article is lightly located at each of the rolling ( The hot water or the like between the respective pure drawing rates are different from each other in order to apply heat to the molded article, and the molded article is stretched at a higher draw ratio. A higher draw ratio supports the effect of increasing the amount of exudation of the suspending active compound by the addition of a branched fatty acid. (4) The stretch ratio of the product is preferably 2 or more, more preferably 4 or more, still more preferably 6 or more. Excessive stretch ratios result in a smaller elongation at break eXtenSi〇n) and a higher Young's modulus. Therefore, from the viewpoint of flexibility and elongation of the obtained yarn, the stretching ratio is 50 or less' more (four) 30 or less, X is more preferably $20 or less, and most preferably 15 or less. The above stretching step does not need to be carried out separately from the extrusion on the same line, i.e., a separate stretching step can be carried out separately, and if there is a subsequent step, the stretching step can be carried out before. The polymer composition of the present invention has excellent melt spinning properties and sufficient melt extrudability (meit_extrudabiHty), and thus is preferably used for producing silk threads such as multifilament yarns 321673 20 201121419 (mi lti fi Lament) and monofilament (monof i lament). The polymer composition of the present invention is more preferably used for the production of monofilament strands. The wire formed by the polymer composition thus has excellent stretchability under heating and has sufficient mechanical strength. When the polymer composition is used to produce a thread, the polymer composition can be broadcast and spun at a higher discharge rate, and thus can be heightened in a one-step stretching operation. The resulting thread is stretched. Therefore, the wire can be manufactured at a lower cost. As a method of forming the polymer composition of the present invention into a yarn, a known molding method such as a melt spinning method or a (direct) spinning/stretching method or the like is used. In effect, the polymer composition is smeared using an extruder or the like, and the molten polymer composition is extruded from a mold nozzle via a gear pump to form a polymer composition strand; The linear polymer composition is smelted and melted, and then cooled by a cooling medium such as water or air for spinning; then the obtained yarn is stretched under heating as needed, heat-treated and coated with oil, and then wound stand up. The cross-sectional shape of the wire is, for example, a circle, an ellipse, a triangle, a rectangle, a hexagon or a star. EXAMPLES Hereinafter, the present invention will be further described by way of examples and comparative examples. In the examples and comparative examples, physical properties were measured according to the following methods. (1) Melt flow rate (MFR, in g/10 mins.) The melt flow rate was measured at a load of 19 0 C, 21. 18 N according to the method established in JIS K7210-1995. (2) Density (in kg/m3) 321673 21 201121419 Density is measured according to the procedure established by Method A in the method described in JIS K7112-1980. The test piece to be measured was annealed according to the method for low density polyethylene formulated in JIS K676-1995. Example 1 (1) Preparation of Releasable Active Compound Support An insect control agent, chlorpheniramine (Eksmin® 'manufactured by Sumitomo Chemical Company, Limited), was used as a release-active compound. The antioxidant 2,6-di-t-butyl-4-methyl-methyl (hereinafter referred to as AO-1) (1.5 parts by weight) was dissolved in chlorpheniramine (51 parts by weight). Then, a mixture of a mixture of chlorpheniramine and A0-1 (52.5 parts by weight) and an amorphous yttrium oxide support (Porous Silica®, manufactured by Suzuki-Oil C., Ltd.) (47. 5 parts by weight) (i.e., mixed with 93.1 parts by weight per 100 parts by weight of chlorpheniramine) to obtain a releasable active compound support. (2) Preparation of polymer composition For olefin-based polymers, high-density polyethylene particles (HI-ZEX® 440M, manufactured by PRIME POLYMER; MFR = 9.9 g/l〇mins.; density = 948 kg/) were used. M3) (100 parts by weight) and a mixture of high-pressure treated low-density polyethylene particles (Sumikathene® G803, manufactured by Sumitomo Chemical Company, Limited) (hereinafter referred to as LD) (9.8 parts by weight) (hereinafter, this is The mixture is referred to as an olefin polymer mixture). The polymer composition of the yarn is prepared by melting and kneading an olefin-based polymer mixture (100 parts by weight), an antioxidant (i.e., at a temperature of about 150 ° C using a Banbury mixer). N-octadecyl-3-(3,5-di-t-butyl-4-phenylphenyl)propionate) (Irganox® 22 321673 201121419 1076 'Manufactured by Ciba Specialty Chemicals κ. κ.) (〇 〇13 Heavy wounds), a releasable active compound support (4.4 parts by weight), and 2-heptylundecanoic acid (hereinafter referred to as isostearic acid 1) (1.4 parts by weight). (3) Prepare a monofilament thread using a 2 〇mm Φ extruder with eight molds (small molds with 4 1 must-have holes), and pass the polymer composition for the yarn through the mold (set to 200 C 'discharge) The rate is 〇. 6 kg / h (kg / hr)). Pull the resulting polymer composition line ' at a line rate of 14 a/knife (m/min) and pass it through a hot water bath followed by 112 m/min Rate pull · · That is, the stretch ratio is 8. Thereby, a monofilament line having a fineness of denier is obtained. (4) Measure the amount of exudation and store the monofilament line in the thermostatic chamber (set to 23. 〇中, 2, after 3 days, 7 days, 14 days, 28 days, and % days later, each The ketone is washed with the ketone to remove the surface of the monofilament thread by blowing nitrogen for cleaning (4); and then using an ethanol control containing 5 〇 PPm + triphenyl benzene as an internal standard. The amount of exudation of the chlorpheniramine was determined by gas chromatography. The measurement using gas chromatography was carried out under the following conditions: Injection volume: 1 μl (# 1) Column. Capillary column DB-1 (County Sound training eight, [length 30 meters (m) 'inner diameter 〇 25 milliseconds (mm), thickness 0 25 microns (#m)) Detector: hydrogen flame free detector (fid)
汽化室溫度：265°C 321673 23 201121419 接著以20°C/分鐘之 偵測器溫度：265°C 管柱溫度：最初一分鐘為5〇°C 速率提升至240°C。 製作用於得到百滅寧尖峰對内標準品尖 量線’以測定百滅寧之參出量。 及 將百滅寧之滲出量除以單絲線之重量，所得之商 (quotient)係定義為每重量單絲線之滲出量。將清洗過^ 單絲線再存放於恆溫室（設定為23。〇中，直到下—測量曰 為止。藉由將3天後（或}天後）、7天後、14天後=天 後以及56天後所測得之渗出量相加以計算百滅寧之累積 滲出量。藉此獲得百滅寧之56天累積滲出量。結示 表1中。 比較例1 依據實施例1之相同方式製備聚合物組成物，惟使用 硬脂酸鋅取代異硬脂酸丨。依據實施例丨之相同方式使用 此聚合物組成物製造單絲線，朗量百滅寧之參出量。結 果顯示於表1中。 ° 比較例2 依據實施例1之相同方式製備聚合物組成物，惟使用 十四酸取代異硬賴1。域實關1之相时式使用此 聚合物組成物製造單絲線，並測量百滅寧之滲出量。結果 顯示於表1中。 比較例3 依據實施例1之相同方式製備聚合物組成物，惟使用 321673 24 201121419 十六酸取代異硬㈣1。依據實施例丨之相门 聚合物組成物製造單絲線，並測量百 。』方式使用此 顯示於表1中。 / 丁之滲出量。結果 比較例4 依據實施例1之相同方式製備聚合物 硬脂酸取代異硬麟丨。依據實施例丨 物，惟使用 聚合物組成物製造單絲線，並測 顯示於表1中。 > 出置、，.D果 比較例5 依據實施例i之相同方式製備聚合·成物，惟使用 :十二酸取代異硬脂酸i。依據實施例 此聚合物线物製造單料。分別於丨天後、使用 錢、28天後以及56天後測量百滅寧。心^ 相加，其總和係定義為百滅寧 ° 示於表”。 T之56天累軸量。結果顯 實施例2 依據實施例1之相同方式製備聚合物、组成物，惟使用 2, 2’4, 8, 10’10-六曱基十一烧相酸（後文中稱為異硬脂 酉欠2)作為支鏈脂肪酸以取代異硬脂酸（。依據實施们之 相同方式制《合物組成物製造單絲線，並測量百滅寧 之滲出量。結果顯示於表1中。 τ 貫施例3 依據實施例1之相同方式製備聚合娜齋n使用 2-正己基癸酸（後文中稱為異十六酸）作為支鍵脂肪酸以取 321673 25 201121419 代異硬脂酸1。依據實施例1之相同方式使用此聚合物組 成物製造單絲線。分別於1天後、7天後、14天後、28天 後以及56天後測量百滅寧之滲出量。將結果相加，其總和 係疋義為百滅甲之5 6天累積滲出量。結果顯示於表1中。 實施例4 依據實施例1之相同方式製造單絲線，惟將熱水浴之 前的拉引速率改為表2中所示之值，且不使單絲線通過熱 水冷，然後測畺百滅争之滲出量。由於單絲線未經拉伸， 因此為了方便起見，乃將拉伸比率假設為丨。分別於i天 後、7天後、14天後、28天後以及56天後測量百滅寧之 滲出量。將結果相加，其總和係定義為百滅寧之56天累積 滲出量。另-方面，分別將i天後、7天後、14天後、找 天後以及56天後所測得之各個百滅寧參出量除以單絲線 之重量以及由前次測量日算起所經過之天數；並且將所得 之商定義為百滅寧之連續參出量（sequent ial We㈣ amours)。關於此連續滲出量之參照天數，係使用介於前次 測量日與此次測量日之間的中間天數。亦即，於丄天後、7 天後、14天後、28天後以及56天後所測量之渗出灸 照天數分別為前次測量後的第〇 5天、4 1 ln , ， . 八兮穴、丄天、21 天以及42天。再者，與後文所述之比較例6 (與拉伸比率 相關）比幸交21天後所測得之連續參出量，並計算彼此間的 比率。結果顯示於表3中。 [實施例5至7] .依據實施例1之相同方式製造單絲線，惟將熱水浴之 321673 26 201121419 f與：ΐ，速率改為表2中所示之值；然後測量百滅 丁之I。拉伸比率係定義為在熱水 供的拉引料之比率。分別於丨天後、7天後、=== 及=8天L渗出量；將所測得之各個滲出量除以由前次 :夏：：起所經過之天數；並將經此轉換之每一天所得的 參出罝疋義為百滅寧之連續滲出量。關於百滅寧之此連續 渗出量的參照天數’係使用介於前次測量日與此次測量曰 之間的中間天數。亦即，於G. 5天後、4天後、10. 5天後 以及21天後之百滅寧的連續滲出量係以丨天後、7天後、 14天後以及28天後所測得之百滅寧滲出量為基準計算。 再者’與後文所述之比較例7至9 (與拉伸比率相關）比較 21天後所·之連續滲出量’並計算其比率。結果顯示於 表3中。 ' 比較例6 依據實施例1之相同方式製備聚合物組成物，惟使用 硬脂酸鋅取代異硬脂酸1。依據實施例丨之相同方式使用 此15物組成物製造早絲線。依據實施例4至7之相同方 式測量百滅寧之滲出量，藉以計算百滅寧之連續滲出量。 結果顯不於表3中。 比較例7至9 依據實施例1之相同方式製備聚合物組成物，惟使用 硬脂酸鋅取代異硬脂酸1 ;以及依據實施例1之相同方式 使用此聚合物組成物製造早絲線，惟將熱水浴之前與之後 的拉引速率改為表2中所示之值。依據實施例4至7之相 27 321673 201121419 同方式測量百滅寧之滲出量，藉以計算百滅寧之連續滲出 量。結果顯示於表3中。 表1 所添加之脂肪酸 百滅寧之5 6天累積渗出量 (β g/g) 實施例1 異硬脂酸1 343 比較例1 硬脂酸鋅 162 比較例2 十四酸 141 比較例3 十六酸 154 比較例4 硬脂酸 168 比較例5 二十二酸 176 實施例2 異硬脂酸2 342 實施例3 異十六酸 329 表2 熱水浴前之 拉引速率 (m/min.) 熱水浴後之 拉引速率 (m/min.) 拉伸比率 丹尼 實施例4 13. 9 — 1 655 比較例6 14 — 1 764 實施例5 14 56 4 204 比較例7 14 56 4 200 實施例6 14 112 8 200 比較例8 14 112 8 204 實施例7 12 120 10 203 比較例9 12 120 10 200 28 321673 201121419 表3 百滅寧之連續渗出量（# g/g/day) 相對於比較例 之21天後百 滅寧連續滲出 量之比率 0· 5天 4天 10. 5 天 21天 實施例4 2053 152 110 62 1. 0 比較例6 1081 130 116 62 — 實施例5 443 138 84 42 1.2 比較例7 343 126 66 36 —— 實施例6 135 14. 3 9. 3 4. 0 1.8 比較例8 57 7. 9 4.4 2. 3 — 實施例7 113 9. 2 5. 6 2. 8 2. 2 比較例9 44 4. 0 2. 1 1. 3 — 【圖式簡單說明】 M. ° < »»、 【主要元件符號說明】 *»»、 29 321673Vaporization chamber temperature: 265 ° C 321673 23 201121419 followed by 20 ° C / min detector temperature: 265 ° C column temperature: the first minute is 5 ° ° C rate is increased to 240 ° C. The amount of the standard product tip line was determined to obtain the Baifenning spike internal standard to determine the amount of the perindoprene. And dividing the exudation amount of the perphenazine into the weight of the monofilament thread, the quotient obtained is defined as the amount of exudation per weight of the monofilament thread. Store the cleaned monofilament thread in a constant temperature room (set to 23. 〇, until the next - measure 曰. After 3 days (or } days later), 7 days later, 14 days later = after the day and The amount of exudation measured after 56 days was added to calculate the cumulative exudation amount of Baishenning, thereby obtaining the cumulative exudation amount of Baisuning for 56 days. The results are shown in Table 1. Comparative Example 1 The same manner as in Example 1 The polymer composition was prepared except that zinc stearate was used in place of bismuth stearate. The polymer composition was used to produce a monofilament thread in the same manner as in Example ,, and the amount of arsenic was measured. The results are shown in the table. 1 . ° Comparative Example 2 A polymer composition was prepared in the same manner as in Example 1, except that tetradecanoic acid was used in place of the iso-hard lysine 1. The phase of the domain was used to produce a monofilament thread using the polymer composition, and The amount of exudation of the chlorpheniramine was measured. The results are shown in Table 1. Comparative Example 3 A polymer composition was prepared in the same manner as in Example 1, except that 321673 24 201121419 hexadecanic acid was substituted for the iso-hard (IV) 1. According to the Example The door polymer composition produces a monofilament thread and measures 100 The manner of use is shown in Table 1. / The amount of exudation. Results Comparative Example 4 A polymer stearic acid was prepared in the same manner as in Example 1 in place of the isodentin. According to the examples, the polymer was used. The composition was used to produce a monofilament thread, and the measurement was shown in Table 1. > Outlet, .D. Comparative Example 5 A polymerization product was prepared in the same manner as in Example i except that: dodecanoic acid was substituted for isostearic acid. i. According to the embodiment, the polymer thread is manufactured as a single material. The chlorination is measured after the day, after the use of the money, after 28 days, and after 56 days. The heart is added, and the sum is defined as the fentanin. In the table, the amount of the axial amount of T was 56 days. Results were as follows. Example 2 A polymer or a composition was prepared in the same manner as in Example 1, except that 2, 2', 4, 8, 10'10-hexadecyl eleven was used. A phase acid (hereinafter referred to as isostearyl oxime 2) is used as a branched chain fatty acid to replace isostearic acid (manufactured in the same manner as in the practice of the composition to make a monofilament line, and to measure the exudation of the chlorpyrifos The results are shown in Table 1. τ Example 3 Preparation of a polymer in the same manner as in Example 1 Nazin n uses 2-n-hexyldecanoic acid (hereinafter referred to as isohexadecanoic acid) as a branched fatty acid to obtain 321673 25 201121419 generation isostearic acid 1. The polymer composition was produced in the same manner as in Example 1. Monofilament line. The amount of exudation of Baishenning was measured after 1 day, 7 days, 14 days, 28 days, and 56 days. The results were added, and the sum of the lines was 5 6 days. The amount of exudation was accumulated. The results are shown in Table 1. Example 4 A monofilament thread was produced in the same manner as in Example 1, except that the drawing rate before the hot water bath was changed to the value shown in Table 2, and the monofilament thread was not made. It is cooled by hot water, and then the amount of exudation is measured. Since the monofilament thread is not stretched, the stretching ratio is assumed to be 丨 for the sake of convenience. The amount of exudation of the chlorpyrifos was measured after i days, 7 days, 14 days, 28 days, and 56 days, respectively. The results are summed and the sum is defined as the 56-day cumulative exudation of Baishenning. On the other hand, the amount of each of the chlorhexidines measured after i days, 7 days, 14 days, after the day, and after 56 days was divided by the weight of the monofilament line and from the previous measurement date. The number of days passed; and the resulting quotient is defined as the sequent ial We (four) amours. The reference days for this continuous exudation amount are the number of days between the previous measurement date and the measurement day. That is, the number of oozing moxibustion days measured after 丄天天, 7 days, 14 days, 28 days, and 56 days is the fifth day after the previous measurement, 4 1 ln , , . Acupoints, scorpion days, 21 days and 42 days. Further, Comparative Example 6 (related to the stretching ratio) described later was compared with the continuous amount of measurement measured after 21 days, and the ratio between each other was calculated. The results are shown in Table 3. [Examples 5 to 7] A monofilament thread was produced in the same manner as in Example 1, except that the hot water bath 321673 26 201121419 f and : ΐ, the rate was changed to the value shown in Table 2; I. The draw ratio is defined as the ratio of the draw to the hot water supply. The amount of exudation in the days after, after 7 days, === and =8 days; the measured amount of each exudation divided by the number of days elapsed from the previous: summer::; The resulting sputum of each day is the continuous exudation of Baishenning. The reference number of days for the continuous exudation of Baishenning' is the intermediate number between the previous measurement date and the current measurement. That is, the continuous exudation amount of Baishenning after G. 5 days, 4 days, 10. 5 days, and 21 days later was measured after days, 7 days, 14 days, and 28 days later. The amount of percolation obtained is based on the calculation. Further, 'the continuous bleeding amount' after 21 days was compared with Comparative Examples 7 to 9 (related to the stretching ratio) described later and the ratio was calculated. The results are shown in Table 3. Comparative Example 6 A polymer composition was prepared in the same manner as in Example 1 except that zinc stearate was used in place of isostearic acid 1. The 15 composition was used to make an early yarn in the same manner as in Example 丨. The amount of percolation of the chlorpyrifos was measured in the same manner as in Examples 4 to 7, whereby the continuous exudation amount of the chlorpyrifos was calculated. The results are not shown in Table 3. Comparative Examples 7 to 9 A polymer composition was prepared in the same manner as in Example 1, except that zinc stearate was used in place of isostearic acid 1; and this polymer composition was used in the same manner as in Example 1 to produce an early yarn. The pull rate before and after the hot water bath was changed to the value shown in Table 2. According to the phases of Examples 4 to 7 27 321673 201121419, the amount of percolation of Baishenning was measured in the same manner, thereby calculating the continuous exudation amount of Baishenning. The results are shown in Table 3. Table 1 Accumulated exudation amount of the fatty acid baixining added (6 g/g) Example 1 Isostearic acid 1 343 Comparative Example 1 Zinc stearate 162 Comparative Example 2 Tetradecan 141 Comparative Example 3 Hexadesic acid 154 Comparative Example 4 Stearic acid 168 Comparative Example 5 Didodecanoic acid 176 Example 2 Isostearic acid 2 342 Example 3 Isohexadecanoic acid 329 Table 2 Pulling rate before hot water bath (m/min .) Pull rate after hot water bath (m/min.) Stretch ratio Danny Example 4 13. 9 - 1 655 Comparative Example 6 14 - 1 764 Example 5 14 56 4 204 Comparative Example 7 14 56 4 200 Example 6 14 112 8 200 Comparative Example 8 14 112 8 204 Example 7 12 120 10 203 Comparative Example 9 12 120 10 200 28 321673 201121419 Table 3 Continuous Exudation of Baishenning (# g/g/day) Relative The ratio of continuous exudation of Baishenning after 21 days of the comparative example was 0.5 days 4 days 10. 5 days 21 days Example 4 2053 152 110 62 1. 0 Comparative Example 6 1081 130 116 62 - Example 5 443 138 84 42 1.2 Comparative Example 7 343 126 66 36 - Example 6 135 14. 3 9. 3 4. 0 1.8 Comparative Example 8 57 7. 9 4.4 2. 3 - Example 7 113 9. 2 5. 6 2. 8 2. 2 Comparative Example 9 44 4. 0 2. 1 1. 3 — [Simple description of the diagram] M. ° < »», [Description of main component symbols] *»», 29 321673